Nn9535-4533
Research payments
$1,591,706
Through program year 2025, $1,591,706 in research payments was reported against Nn9535-4533, across 9,118 payments.
- Paid by (largest first)
- Novo Nordisk AS; Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $128,570 | 36 |
| 2024 | Research | $156,705 | 86 |
| 2023 | Research | $344,349 | 708 |
| 2022 | Research | $498,803 | 2,015 |
| 2021 | Research | $427,354 | 5,034 |
| 2020 | Research | $35,926 | 1,239 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Iraklis Pipinos Omaha, NE Named on 638 payments
- Neda Rasouli Aurora, CO Named on 555 payments
- Mark Nehler Aurora, CO Named on 427 payments
- Cezar Staniloae New York, NY Named on 246 payments
- Mohd Qamar Glenview, IL Named on 219 payments
- Sureka Bollepalli Tampa, FL Named on 212 payments
- Ravi Kamepalli Lagrange, GA Named on 210 payments
- Janaki Nadarajah Martinez, GA Named on 210 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.